CME Group Inc.
CME · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $97 | $99 | $95 | $83 |
| - Cash | $2 | $2 | $1 | $3 |
| + Debt | $3 | $3 | $3 | $3 |
| Enterprise Value | $98 | $101 | $97 | $84 |
| Revenue | $2 | $2 | $2 | $2 |
| % Growth | -9.1% | 3% | 7.7% | – |
| Gross Profit | $1 | $1 | $1 | $1 |
| % Margin | 84.5% | 86.9% | 87.4% | 85.5% |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 84.8% | 86.2% | 83.4% | 80% |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 59.1% | 59.8% | 58.2% | 57.3% |
| EPS Diluted | 2.49 | 2.81 | 2.62 | 2.4 |
| % Growth | -11.4% | 7.3% | 9.2% | – |
| Operating Cash Flow | $1 | $1 | $1 | $1 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $1 | $1 | $1 | $1 |